| East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort J Burisch, N Pedersen, S Čuković-Čavka, M Brinar, I Kaimakliotis, ... Gut 63 (4), 588-597, 2014 | 564 | 2014 |
| Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials BG Feagan, WJ Sandborn, U Mittmann, S Bar-Meir, G D’Haens, ... Jama 299 (14), 1690-1697, 2008 | 348 | 2008 |
| Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial W Kruis, G Kiudelis, I Racz, IA Gorelov, J Pokrotnieks, M Horynski, ... Gut 58 (2), 233-240, 2009 | 252 | 2009 |
| Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study J Burisch, G Kiudelis, L Kupcinskas, HAL Kievit, KW Andersen, ... Gut 68 (3), 423-433, 2019 | 236 | 2019 |
| Geographical patterns of the standing and active human gut microbiome in health and IBD A Rehman, P Rausch, J Wang, J Skieceviciene, G Kiudelis, K Bhagalia, ... Gut 65 (2), 238-248, 2016 | 180 | 2016 |
| Natural disease course of ulcerative colitis during the first five years of follow-up in a European population-based inception cohort—an Epi-IBD study J Burisch, KH Katsanos, DK Christodoulou, L Barros, F Magro, ... Journal of Crohn's and Colitis 13 (2), 198-208, 2019 | 135 | 2019 |
| Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe—An ECCO-EpiCom study J Burisch, N Pedersen, S Cukovic-Cavka, N Turk, I Kaimakliotis, ... Journal of Crohn's and Colitis 8 (7), 607-616, 2014 | 123 | 2014 |
| Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized … L Kupcinskas, P Lafolie, Å Lignell, G Kiudelis, L Jonaitis, K Adamonis, ... Phytomedicine 15 (6-7), 391-399, 2008 | 116 | 2008 |
| Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis V Gross, S BAR‐MEIR, A Lavy, O Mickisch, Z Tulassay, L Pronai, ... Alimentary pharmacology & therapeutics 23 (2), 303-312, 2006 | 113 | 2006 |
| The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology M Leja, L Kupcinskas, K Funka, A Sudraba, L Jonaitis, A Ivanauskas, ... Digestive diseases and sciences 54, 2377-2384, 2009 | 104 | 2009 |
| Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study J Burisch, H Vardi, D Schwartz, M Friger, G Kiudelis, J Kupčinskas, ... The lancet Gastroenterology & hepatology 5 (5), 454-464, 2020 | 99 | 2020 |
| Gene Polymorphisms of Micrornas in Helicobacter pylori-Induced High Risk Atrophic Gastritis and Gastric Cancer J Kupcinskas, T Wex, A Link, M Leja, I Bruzaite, R Steponaitiene, ... PloS one 9 (1), e87467, 2014 | 87 | 2014 |
| Lack of association between miR-27a, miR-146a, miR-196a-2, miR-492 and miR-608 gene polymorphisms and colorectal cancer J Kupcinskas, I Bruzaite, S Juzenas, U Gyvyte, L Jonaitis, G Kiudelis, ... Scientific reports 4 (1), 5993, 2014 | 80 | 2014 |
| Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori … J Kupcinskas, T Wex, J Bornschein, M Selgrad, M Leja, E Juozaityte, ... BMC medical genetics 12, 1-9, 2011 | 79 | 2011 |
| Gastric inflammatory markers and interleukins in patients with functional dyspepsia treated with astaxanthin LP Andersen, S Holck, L Kupcinskas, G Kiudelis, L Jonaitis, ... FEMS Immunology & Medical Microbiology 50 (2), 244-248, 2007 | 72 | 2007 |
| 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: a double-blind, double-dummy, randomised trial V Gross, I Bunganic, EA Belousova, TL Mikhailova, L Kupcinskas, ... Journal of Crohn's and Colitis 5 (2), 129-138, 2011 | 70 | 2011 |
| Increased prevalence of subclinical hypothyroidism in common bile duct stone patients J Laukkarinen, G Kiudelis, M Lempinen, S Räty, H Pelli, J Sand, ... The Journal of Clinical Endocrinology & Metabolism 92 (11), 4260-4264, 2007 | 68 | 2007 |
| Analysis of deregulated microRNAs and their target genes in gastric cancer S Juzėnas, V Saltenienė, J Kupcinskas, A Link, G Kiudelis, L Jonaitis, ... PloS one 10 (7), e0132327, 2015 | 55* | 2015 |
| Characteristics of patients with erosive and nonerosive Gerd in high-Helicobacter-pylori prevalence region LV Jonaitis, G Kiudelis, L Kupcinskas Diseases of the Esophagus 17 (3), 223-227, 2004 | 47 | 2004 |
| Gastric inflammatory markers and interleukins in patients with functional dyspepsia, with and without Helicobacter pylori infection LP Andersen, S Holck, D Janulaityte-Günther, L Kupcinskas, G Kiudelis, ... FEMS Immunology & Medical Microbiology 44 (2), 233-238, 2005 | 46 | 2005 |
